Literature DB >> 9121177

Evidence against flat dysplasia as a regional field defect in small bowel adenocarcinoma associated with celiac sprue.

C J Bruno1, K P Batts, D A Ahlquist.   

Abstract

OBJECTIVE: To determine whether diffuse flat dysplasia, akin to that seen with chronic ulcerative colitis, occurs as a mucosal field defect accompanying small bowel adenocarcinoma in patients with celiac sprue.
DESIGN: A pathologic investigation of archival tissue was undertaken.
MATERIAL AND METHODS: From the tissue archives at Mayo Clinic Rochester for the period from January 1978 to January 1993, resected sprue-associated adenocarcinomas with adequate adjacent mucosa for study were identified. On the basis of multiple strip biopsy specimens obtained at the tumor margins and within 4 cm distal and proximal to the tumor, histologic maps were created.
RESULTS: Among 94 patients with primary adenocarcinoma of the small bowel, 8 had a concurrent diagnosis of celiac sprue. Of these eight cases, six surgically resected specimens (five duodenal and one jejunal adenocarcinoma) were adequate for study. A thin rim of benign dysplasia was demonstrated at the tumor margin in three of the six specimens; however, contiguous fields of flat dysplasia were not present in any of these cases.
CONCLUSION: These data support focal dysplasia (for example, adenoma) rather than sheets of flat dysplasia as the premalignant lesion in sprue-associated small bowel adenocarcinoma. Blind endoscopic biopsies of small bowel mucosa are not justified for neoplasia surveillance in patients with celiac sprue.

Entities:  

Mesh:

Year:  1997        PMID: 9121177     DOI: 10.4065/72.4.320

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  7 in total

1.  North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.

Authors:  Robert R McWilliams; Nathan R Foster; Michelle R Mahoney; Thomas C Smyrk; Joseph A Murray; Matthew M Ames; L Elise Horvath; Daniel J Schneider; Timothy J Hobday; Aminah Jatoi; Jeffrey P Meyers; Matthew P Goetz
Journal:  Cancer       Date:  2017-05-10       Impact factor: 6.860

2.  Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.

Authors:  Alessandro Vanoli; Antonio Di Sabatino; Michele Martino; Catherine Klersy; Federica Grillo; Claudia Mescoli; Gabriella Nesi; Umberto Volta; Daniele Fornino; Ombretta Luinetti; Paolo Fociani; Vincenzo Villanacci; Francesco P D'Armiento; Renato Cannizzaro; Giovanni Latella; Carolina Ciacci; Livia Biancone; Marco Paulli; Fausto Sessa; Massimo Rugge; Roberto Fiocca; Gino R Corazza; Enrico Solcia
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

3.  Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue.

Authors:  I Barshack; I Goldberg; Y Chowers; B Weiss; A Horowitz; J Kopolovic
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

4.  Small bowel neoplasia in coeliac disease.

Authors:  S D Rampertab; K A Forde; P H R Green
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 5.  Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations.

Authors:  Alessandro Vanoli; Federica Grillo; Daniela Furlan; Giovanni Arpa; Oneda Grami; Camilla Guerini; Roberta Riboni; Luca Mastracci; Antonio Di Sabatino
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

6.  Small Bowel Adenocarcinoma as the Cause of Gastrointestinal Bleeding in Celiac Disease: A Rare Malignancy in a Common Disease.

Authors:  Jaleh Fallah; Maxwell Eyram Afari; Alfredo C Cordova; Adam J Olszewski; Taro Minami
Journal:  Case Rep Oncol Med       Date:  2015-07-28

7.  Delayed diagnosis of coeliac disease increases cancer risk.

Authors:  Marco Silano; Umberto Volta; Anna Maria Mecchia; Mariarita Dessì; Rita Di Benedetto; Massimo De Vincenzi
Journal:  BMC Gastroenterol       Date:  2007-03-09       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.